Ubs Asset Management Americas Inc Regenxbio Inc. Transaction History

Ubs Asset Management Americas Inc

$345 Billion
Q2 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Regenxbio Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 70,958 shares of RGNX stock, worth $724,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,958

Previous 38,544 84.1%

Holding current value

$724,481

Previous $812,000 2.22%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$11.51 - $21.53 $373,085 - $697,873	32,414 Added 84.1%	70,958 $830,000
Q3 2023 Nov 13, 2023	BUY	$16.46 - $19.99 $217,881 - $264,607	13,237 Added 52.31%	38,544 $634,000
Q1 2023 May 15, 2023	SELL	$18.08 - $24.55 $166,173 - $225,639	-9,191 Reduced 26.64%	25,307 $478,000
Q4 2022 Feb 14, 2023	SELL	$20.4 - $24.73 $40,738 - $49,385	-1,997 Reduced 5.47%	34,498 $782,000
Q2 2022 Aug 12, 2022	SELL	$19.35 - $35.04 $25,058 - $45,376	-1,295 Reduced 3.43%	36,495 $901,000
Q3 2021 Nov 15, 2021	SELL	$29.09 - $45.68 $48,085 - $75,509	-1,653 Reduced 4.19%	37,790 $1.58 Million
Q2 2021 Aug 16, 2021	BUY	$32.46 - $40.48 $84,785 - $105,733	2,612 Added 7.09%	39,443 $1.53 Million
Q1 2021 May 14, 2021	BUY	$33.61 - $49.95 $334,117 - $496,552	9,941 Added 36.97%	36,831 $1.26 Million
Q2 2020 Aug 14, 2020	BUY	$27.75 - $43.44 $125,568 - $196,566	4,525 Added 20.23%	26,890 $990,000
Q1 2020 May 15, 2020	SELL	$21.5 - $54.2 $2.12 Million - $5.35 Million	-98,759 Reduced 81.54%	22,365 $724,000
Q4 2019 Feb 14, 2020	BUY	$34.54 - $44.87 $24,834 - $32,261	719 Added 0.6%	121,124 $4.96 Million
Q3 2019 Nov 14, 2019	BUY	$31.84 - $50.88 $22,001 - $35,158	691 Added 0.58%	120,405 $4.29 Million
Q2 2019 Aug 15, 2019	BUY	$42.0 - $59.29 $31,584 - $44,586	752 Added 0.63%	119,714 $0
Q1 2019 May 14, 2019	BUY	$40.82 - $62.45 $393,423 - $601,893	9,638 Added 8.82%	118,962 $0
Q4 2018 Feb 13, 2019	SELL	$39.11 - $75.15 $251,359 - $482,989	-6,427 Reduced 5.55%	109,324 $4.59 Million
Q3 2018 Nov 14, 2018	BUY	$65.0 - $82.15 $6.74 Million - $8.51 Million	103,628 Added 854.8%	115,751 $0
Q2 2018 Aug 14, 2018	BUY	$27.2 - $74.35 $329,745 - $901,345	12,123 New	12,123 $0

Others Institutions Holding RGNX

# of Institutions

192

Shares Held

43.5M

Call Options Held

58.9K

Put Options Held

58.4K

View Full List

About REGENXBIO Inc.

Ticker RGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,230,000
Market Cap $441M
Description
REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...

More about RGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Regenxbio Inc. Transaction History